Update of the androgen receptor gene mutations database

Human Mutation

Volumn 14, Issue 2, 1999, Pages 103-114

  Gottlieb, Bruce ^a,c   Beitel, Lenore K ^a   Lumbroso, Rose ^a   Pinsky, Leonard ^a,b   Trifiro, Mark ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c JOHN ABBOTT COLLEGE   (Canada)

Author keywords

AR; Database; Hotspot; Interacting proteins

Indexed keywords

ANDROGEN RECEPTOR; PROTEIN;

ARTICLE; DATA BASE; EXON; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTERNET; MALE; MALE INFERTILITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN STRUCTURE; RECEPTOR BINDING;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; DATABASES; EXONS; HUMANS; INFERTILITY; INTERNET; INTRONS; MALE; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 0032808270     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1999)14:2<103::AID-HUMU2>3.0.CO;2-A     Document Type: Article

References (70)

1. Aarnisalo P, Palvimo JJ, Janne OA. 1998. CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci USA 95:2122-2127.
2. Batch JA, Williams DM, Davies HR, Brown BD, Evans BAJ, Hughes, IA, Patterson MN. 1992. Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet 1:497-503.
3. Beitel LK, Kazemi-Esfarjani P, Trifiro MA., Kaufman M, Lumbroso R, DiGeorge AM, Killinger D, Pinsky L. 1994. Substitution of arginine 839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance. J Clin Invest 94:546-554.
4. Beitel LK, de Tourreil AS, Pinsky L, Trifiro M. 1997. Fishing for androgen receptor-associated proteins involved in the pathogenesis of spinobulbar muscular atrophy. In: Program of the 79th Endocrine Society Meeting, Abstr P3-391.
5. Beitel LK, Lumbroso R, Panet-Raymond V, Beauchemin A, Pinsky L, Trifiro MA. 1998. Androgen receptor-interacting proteins isolated using the expanded polyglutamine region implicated in the pathogenesis of spinobulbar muscular atrophy as bait. In: Program of the 80th Endocrine Society Meeting, Abstr OR34-4.
6. Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkman AO. 1998. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol Endocrinol 12:1172-1183.
7. Bonagura TW, Corden JL, Brown TR. 1998. Interaction of a transcriptional coactivator with normal and mutant androgen receptors. In: Program of the 80th Endocrine Society Meeting, Abstr P1-537.
8. Boutell JM, Wood JD, Harper PS, Jones AL. 1998. Huntingtin interacts with cystathionine beta-synthase. Hum Mol Genet 7:371-378.
9. Brinkmann AO, Jenster, G, Ris-Stalpers C, van der Korpu JAGM, Bruggenwirth HT, Boehmer ALM, Trapman J. 1995. Androgen receptor mutations. J Steroid Biochem Mol Biol 53:443-448.
10. Bubulya A, Wise SC, Shen XQ, Burmeister LA, Shemshedini L. 1996. c-Jun can mediate androgen receptor-induced transactivation. J Biol Chem 71:24583-24589.
11. Caplan AJ, Langley E, Wilson EM, Vidal J. 1995. Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. J Biol Chem 270:5251-5257.
12. Chen SY, Wang J, Yu GQ, Liu W, Pearce D. 1997. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J Biol Chem 272:14087-14092.
13. Cheng XB, Reginato MJ, Andrews NC, Lazar MA. 1997. The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bzip protein p45/nf-e2. Mol Cell Biol 17:1407-1416.
14. Crocitto LE, Henderson BE, Coetzee GA. 1997. Identification of two germline point mutations in the 5′UTR of the androgen receptor gene in men with prostate cancer. J Urol 158:1599-1601.
15. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H. 1993. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541-1551.
16. Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, Filmus J, Hawley RG Bruchovsky N, Cheng H, Matusik RJ. 1994. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483.
17. Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O, Vikho P. 1995. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 80:3494-3500.
18. Evans BAJ, Harper ME, Daniells CE, Watts CE, Matenhelia S, Green L, Griffiths K. 1996. Low incidence of androgen receptor gene mutations in human prostatic mutations using single strand conformation polymorphism analysis. Prostate 26:162-171.
19. Fujimoto N, Yeh S, Inui S, Kang H, Chang C. 1998. Isolation and characterization of TGFβ1-inducible androgen receptor-associated protein ARA55. In: Program of the 80th Endocrine Society Meeting, Abstr P1-539.
20. Gao TS, Brantley K, Bolu E, McPhaul MJ. 1998. Proteins that interact with the amino terminus of the human androgen receptor (AR) exert major effects on AR function in eukaryotic cells. In: Program of the 80th Endocrine Society, Abstr OR48-1.
21. Gottlieb B, Trifiro M, Lumbroso R, Vasiliou DM, Pinsky L. 1996. The androgen receptor gene mutations database. Nucleic Acids Res 24:151-154.
22. Gottlieb B, Trifiro M, Lumbroso R, Pinsky L. 1997. The androgen receptor gene mutations database. Nucleic Acids Res 25:158-162.
23. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. 1998. The androgen receptor gene mutations database. Nucleic Acids Res 26:234-238.
24. Haldane JBS. 1935. The rate of spontaneous mutation of a human gene. J Genet 31:317-326.
25. Hiort O, Wodtke A, Struve D, Zollner A, Sinnecker GHG, and the German Collaborative Intersex Study Group. 1994a. Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis. Hum Mol Genet 3:1163-1166.
26. Hiort O, Klauber G Cendron M, Sinnecker GHG, Keim L, Schwinger E, Wolfe HJ, Yandell DW. 1994b. Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr 153:317-321.
27. Hiort O, Sinnecker GHG, Holterhus P-M. Nitsche EM, Kruse K. 1996. The clinical and molecular spectrum of androgen insensitivity syndromes. Am J Med Genet 63:218-222.
28. Hiort O, Sinnecker GHG, Holterhus P-M, Nitsche EM, Kruse K. 1998a. Inherited and de novo androgen receptor gene mutations: investigation of single-case families. J Pediatr 132:939-943.
29. Hiort O, Holterhus P-M, Schultze W, Horter T, Sinnecker GHG. 1998b. Androgen insensitivity in infertile males - endocrine and molecular genetic abnormalities. In: Program of the 80th Endocrine Society Meeting, Abstr P2-38.
30. Holterhus PM, Bruggenwirth HT, Hiort O, Kleinkauf-Houcken A, Kruse K, Sinnecker GHG, Brinkmann AO. 1997. Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. J Clin Endocrinol Metab 82:3584-3589.
31. Hong H, Kohli K, Garabedian MJ, Stallcup MR. 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744.
32. Ikonen T Palvimo JJ, Janne OA. 1997. Interaction between the amino-and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 272:29821-29828.
33. James AJ, Marcelli M, Lamb DJ, Weigel NL. 1997. Functional analysis of androgen receptor mutants identified in human prostate cancer. In: Program of the 79th Endocrine Society Meeting, Abstr P2-484.
34. Kallio PJ, Poukka H, Moilanen A, Janne OA, Palvimo JJ. 1995. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol 9:1017-1028.
35. Klocker H, Kaspar F, Eberle J, Uberreiter S, Radmayr C, Bartsch G. 1992. Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet 50:1318-1327.
36. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY. 1996. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5:1311-1318.
37. Kupfer SR, Marschke KB, Wilson EM, French FS. 1993. Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J Biol Chem 268: 17519-17527.
38. Kupfer SR, Wilson EM, French FS. 1994. Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J Biol Chem 269:20622-20628.
39. La Spada AR, Wilson EM, Luban DB, Harding AE, Fischbeck KH. 1991. Androgen receptor gene mutations in X-linked spinal bulbar muscular atrophy. Nature 352:77-79.
40. Lu J, Danielson M. 1996. A Stul polymorphism in the human androgen receptor gene (AR). Clin Genet 49:323-324.
41. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM. 1988. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-1275.
42. Lumbroso S, Larger Pier A, Audran F, Lobaccaro JM, Poujol N, Larget Piet L, Sultan C. 1996. An 8-base pair duplication in the androgen receptor gene in a family with complete androgen insensitivity syndrome leads to the deletion of DNA-and ligand-binding domains. In: Proceedings of the 10th Int Cong Endocrinol, Abstr P1-182.
43. McEwan IJ, Gustafsson J. 1997. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci USA 94:8485-8490.
44. McPhaul MJ, Marcelli S, Zoppi S, Griffin JE, Wilson JD. 1993. Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J Clin Endocrinol Metab 76:17-23.
45. 4-type zinc finger protein that interacts with androgen receptor. In: Program of the 79th Endocrine Society Meeting, Abstr P2-471.
46. Moilanen A-M, Karvonen U, Poukka H, Janne OA, Palvimo JJ. 1998. Identification of a novel androgen receptor interacting protein - a homolog of the transcriptional repressor PIAS3. In: Program of the 80th Endocrine Society Meeting ,Abstr OR34-6.
47. Nordenskjold A, Sidereal S. 1998. An androgen receptor gene mutation (A645D) in a boy with a normal phenotype. Hum Mutat 11:339.
48. Paz A, Linder A, Zisman A, Siegal Y. 1997. A genetic sequence change in the 3′-noncoding region of the androgen receptor gene in prostate carcinoma. Eur Urol 31:209-215.
49. Pinsky L, Trifiro M, Kaufman M, Beitel L, Mhatre A, Kazemi-Esfarjani P, Sabbaghian N, Lumbroso R, Alvarado C, Vasiliou M, Gottlieb B. 1992. Androgen resistance due to mutation of the androgen receptor. Clin Invest Med 15:456-472.
50. Poukka H, Santti H, Moilanen A, Palvimo JJ, Janne OA. 1998. Mutations in the DNA-binding domain of androgen receptor impair transcriptional enhancement by the coregulator SNURF. In: Program of the 80th Endocrine Society Meeting, Abstr P1-530.
51. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS. 1995. Androgen receptor defects; Historical, clinical, and molecular perspectives. Endocrine Rev 16:271-321.
52. Ris-Stalpers C, Verleun-Mooijman MCT, de Blaeij TJP, Dagenhart HJ, Trapman J, Brinkmann AO. 1994. Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch site. Am J Hum Genet 54:609-617.
53. Reutens AT, Watanabe G, Albanese C, McPhaul MJ, Balk SP, Pestell RG. 1998. Cyclin D1 binds activating mutants of the androgen receptor. In: Program of the 80th Endocrine Society Meeting, Abstr P1-528.
54. Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, et al. 1997. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-jun in the human prostate cancer cell line LNCaP. J Biol Chem 272:17485-17494.
55. Schneikert J, Peterziel H, Defossez PA, Klocker H, Launoit Y, Cato AC. 1996. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J Biol Chem 271:23907-23913.
56. Shkolny DL, Beitel LK, Ginsberg J, Pekeles G, Arbour L, Pinsky L, Trifiro MA. 1999. Discordant measures of the androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively. J Clin Endocrinol Metab 84:805-810.
57. Sultan C, Lumbroso S, Poujol N, Belon C, Boudon C, Lobaccaro J-M. 1993. Mutations of the androgen receptor gene in androgen insensitivity syndromes. J Steroid Biochem Mol Biol 46:519-530.
58. Taplin ME, Bubley GJ, Shuster TD., Frantz, M.E., Spooner, AE, Ogata GK, Keer HN, Balk SP. 1995. Mutation of the androgen-receptor gene in metatstatic androgen-independent prostate cancer. N Engl J Med 332:1393-1398.
59. Tilley WD, Buchanan G, Hickey TE, Bentel JM. 1996. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 2:277-285.
60. Thenot S, Henriqet C, Rochefort H, Cavailles V. 1997. Differential interaction of nuclear receptors with putative human transcriptional coactivator HTIF1. J Biol Chem 272:12062-12068.
61. Urushibata T, Iwatake H, Kaneko T, Kato I. 1996. Androgen receptor gene mutation and androgen-induced cell death in laryngeal carcinoma cell line. In: Proceedings of the 10th International Congress on Endocrinology, Abstr P3-706.
62. Vasiliou M, Trifiro M, Pinsky L. 1994. Mutations in the N-terminal domain of the human androgen receptor associated with androgen resistance syndrome. In: Program of the 76th Endocrine Society Meeting, Abstr 1179.
63. Veldscholte J, Ris-Stalpers C, Kuiper GGMJ, Jenster G, Berrevoets C, Claassen E, van Rooij HCJ, Trapman J, Brinkmann AO, Mulder E. 1990. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534-540.
64. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675.
65. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H. 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 17:507-519.
66. Wang Q, Ghadessy FJ, Yong EL. 1998. Analysis of the transactivation domain of the androgen receptor in patients with male infertility. Clin Genet 54:185-192.
67. Weidemann W, Peters B, Romalo G, Spindler KD, Schwekert HU. 1998. Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor. J Clin Endocrinol Metab 83:1173-1176.
68. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ, Stratton MR. 1992. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2:132-134.
69. Yeh S, Chang C. 1996. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93:5517-5521.
70. Yong EL, Ng SC, Roy AC, Yun G, Ratnam SS. 1994. Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in the androgen receptor gene. Lancet 334: 826-827.